<li>adalimumab<p>adalimumab and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>adenovirus types 4 and 7 live, oral<p>mycophenolate decreases effects of adenovirus types 4 and 7 live, oral by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Immunosuppressives may diminish therapeutic effects of vaccines and increase risk of adverse effects (increased risk of infection). Live-attenuated vaccines should be avoided for at least 3mo after cessation of immunosuppressive therapy.</p></li><li>alefacept<p>alefacept and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>amoxicillin<p>amoxicillin will decrease the level or effect of mycophenolate by  Other (see comment). Avoid or Use Alternate Drug. Effect may be due to impairment of enterohepatic recirculation</p></li><li>ampicillin<p>ampicillin, mycophenolate.
Either increases levels of the other by decreasing renal clearance. Avoid or Use Alternate Drug.</p></li><li>anakinra<p>anakinra and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>anthrax vaccine<p>mycophenolate decreases effects of anthrax vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>antithymocyte globulin equine<p>antithymocyte globulin equine and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>antithymocyte globulin rabbit<p>antithymocyte globulin rabbit and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>azathioprine<p>azathioprine and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>basiliximab<p>basiliximab and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>bcg vaccine live<p>mycophenolate decreases effects of bcg vaccine live by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>canakinumab<p>canakinumab and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>carbonyl iron<p>carbonyl iron decreases levels of mycophenolate by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Interaction only with oral iron administration.</p></li><li>cyclosporine<p>cyclosporine and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.<span><br><br></span>cyclosporine will decrease the level or effect of mycophenolate by  Other (see comment). Avoid or Use Alternate Drug. Cyclosporine A interferes with MPA enterohepatic recirculation;  changes in MPA exposure expected when switching patients from cyclosporine A to one of the immunosuppressants which do not interfere with MPAâ€™s enterohepatic cycle (e.g. tacrolimus;belatacept) </p></li><li>diphtheria &amp; tetanus toxoids<p>mycophenolate decreases effects of diphtheria &amp; tetanus toxoids by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>diphtheria &amp; tetanus toxoids/ acellular pertussis vaccine<p>mycophenolate decreases effects of diphtheria &amp; tetanus toxoids/ acellular pertussis vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>diphtheria &amp; tetanus toxoids/acellular pertussis/poliovirus, inactivated vaccine<p>mycophenolate decreases effects of diphtheria &amp; tetanus toxoids/acellular pertussis/poliovirus, inactivated vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>etanercept<p>etanercept and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>ethinylestradiol<p>mycophenolate decreases effects of ethinylestradiol by unknown mechanism. Avoid or Use Alternate Drug. Patients should consider using an alternative or additional form of contraception.</p></li><li>everolimus<p>everolimus and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>ferrous fumarate<p>ferrous fumarate decreases levels of mycophenolate by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Interaction only with oral iron administration.</p></li><li>ferrous gluconate<p>ferrous gluconate decreases levels of mycophenolate by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Interaction only with oral iron administration.</p></li><li>ferrous sulfate<p>ferrous sulfate decreases levels of mycophenolate by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Interaction only with oral iron administration.</p></li><li>flucloxacillin<p>flucloxacillin, mycophenolate.
Either increases levels of the other by decreasing renal clearance. Avoid or Use Alternate Drug.</p></li><li>glatiramer<p>glatiramer and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>golimumab<p>golimumab and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>haemophilus influenzae type b vaccine<p>mycophenolate decreases effects of haemophilus influenzae type b vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>hepatitis a vaccine inactivated<p>mycophenolate decreases effects of hepatitis a vaccine inactivated by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>hepatitis a/b vaccine<p>mycophenolate decreases effects of hepatitis a/b vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>hepatitis a/typhoid vaccine<p>mycophenolate decreases effects of hepatitis a/typhoid vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>hepatitis b vaccine<p>mycophenolate decreases effects of hepatitis b vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>human papillomavirus vaccine, bivalent<p>mycophenolate decreases effects of human papillomavirus vaccine, bivalent by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, and corticosteroids (used in greater than physiologic doses), may reduce the immune responses to vaccines.</p></li><li>human papillomavirus vaccine, nonavalent<p>mycophenolate decreases effects of human papillomavirus vaccine, nonavalent by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, and corticosteroids (used in greater than physiologic doses), may reduce the immune responses to vaccines.</p></li><li>human papillomavirus vaccine, quadrivalent<p>mycophenolate decreases effects of human papillomavirus vaccine, quadrivalent by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Immunosuppressive therapies, including irradiation, antimetabolites, alkylating agents, cytotoxic drugs, and corticosteroids (used in greater than physiologic doses), may reduce the immune responses to vaccines.</p></li><li>hydroxychloroquine sulfate<p>hydroxychloroquine sulfate and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>infliximab<p>infliximab and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>influenza virus vaccine quadrivalent<p>mycophenolate decreases effects of influenza virus vaccine quadrivalent by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>influenza virus vaccine quadrivalent, intranasal<p>mycophenolate decreases effects of influenza virus vaccine quadrivalent, intranasal by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>influenza virus vaccine trivalent<p>mycophenolate decreases effects of influenza virus vaccine trivalent by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>influenza virus vaccine trivalent, adjuvanted<p>mycophenolate decreases effects of influenza virus vaccine trivalent, adjuvanted by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Immunosuppressive drugs may reduce the immune response to influenza vaccine.</p></li><li>iron dextran complex<p>iron dextran complex decreases levels of mycophenolate by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Interaction only with oral iron administration.</p></li><li>iron sucrose<p>iron sucrose decreases levels of mycophenolate by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Interaction only with oral iron administration.</p></li><li>japanese encephalitis virus vaccine<p>mycophenolate decreases effects of japanese encephalitis virus vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>leflunomide<p>leflunomide and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>measles (rubeola) vaccine<p>mycophenolate decreases effects of measles (rubeola) vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>measles mumps and rubella vaccine, live<p>mycophenolate decreases effects of measles mumps and rubella vaccine, live by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>measles, mumps, rubella and varicella vaccine, live<p>mycophenolate decreases effects of measles, mumps, rubella and varicella vaccine, live by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>meningococcal a c y and w-135 polysaccharide vaccine combined<p>mycophenolate decreases effects of meningococcal a c y and w-135 polysaccharide vaccine combined by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>muromonab cd3<p>muromonab cd3 and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>nafcillin<p>nafcillin, mycophenolate.
Either increases levels of the other by decreasing renal clearance. Avoid or Use Alternate Drug.</p></li><li>pivmecillinam<p>pivmecillinam, mycophenolate.
Either increases levels of the other by decreasing renal clearance. Avoid or Use Alternate Drug.</p></li><li>pneumococcal vaccine 13-valent<p>mycophenolate decreases effects of pneumococcal vaccine 13-valent by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>pneumococcal vaccine heptavalent<p>mycophenolate decreases effects of pneumococcal vaccine heptavalent by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>pneumococcal vaccine polyvalent<p>mycophenolate decreases effects of pneumococcal vaccine polyvalent by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>poliovirus vaccine inactivated<p>mycophenolate decreases effects of poliovirus vaccine inactivated by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>poliovirus vaccine live oral trivalent<p>mycophenolate decreases effects of poliovirus vaccine live oral trivalent by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>polysaccharide iron<p>polysaccharide iron decreases levels of mycophenolate by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Interaction only with oral iron administration.</p></li><li>quinidine<p>quinidine will increase the level or effect of mycophenolate by  P-glycoprotein (MDR1) efflux transporter. Avoid or Use Alternate Drug.</p></li><li>rabies vaccine<p>mycophenolate decreases effects of rabies vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants may interfere with development of active immunity.</p></li><li>rabies vaccine chick embryo cell derived<p>mycophenolate decreases effects of rabies vaccine chick embryo cell derived by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>rilonacept<p>mycophenolate and rilonacept both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>rose hips<p>rose hips decreases levels of mycophenolate by inhibition of GI absorption. Applies only to oral form of both agents. Avoid or Use Alternate Drug. Interaction only with oral iron administration.</p></li><li>rotavirus oral vaccine, live<p>mycophenolate decreases effects of rotavirus oral vaccine, live by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>rubella vaccine<p>mycophenolate decreases effects of rubella vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>sirolimus<p>mycophenolate and sirolimus both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>smallpox (vaccinia) vaccine, live<p>mycophenolate decreases effects of smallpox (vaccinia) vaccine, live by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>tacrolimus<p>mycophenolate and tacrolimus both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>temocillin<p>temocillin, mycophenolate.
Either increases levels of the other by decreasing renal clearance. Avoid or Use Alternate Drug.</p></li><li>temsirolimus<p>mycophenolate and temsirolimus both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>tetanus toxoid adsorbed or fluid<p>mycophenolate decreases effects of tetanus toxoid adsorbed or fluid by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>ticarcillin<p>ticarcillin, mycophenolate.
Either increases levels of the other by decreasing renal clearance. Avoid or Use Alternate Drug.</p></li><li>tick borne encephalitis vaccine<p>mycophenolate decreases effects of tick borne encephalitis vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>tocilizumab<p>tocilizumab and mycophenolate both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>tofacitinib<p>mycophenolate, tofacitinib.
Either increases toxicity of the other by immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>tongkat ali<p>mycophenolate and tongkat ali both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>travelers diarrhea and cholera vaccine inactivated<p>mycophenolate decreases effects of travelers diarrhea and cholera vaccine inactivated by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>typhoid polysaccharide vaccine<p>mycophenolate decreases effects of typhoid polysaccharide vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>typhoid vaccine live<p>mycophenolate decreases effects of typhoid vaccine live by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>ustekinumab<p>mycophenolate and ustekinumab both increase  immunosuppressive effects; risk of infection. Avoid or Use Alternate Drug.</p></li><li>varicella virus vaccine live<p>mycophenolate decreases effects of varicella virus vaccine live by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>yellow fever vaccine<p>mycophenolate decreases effects of yellow fever vaccine by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li><li>zoster vaccine live<p>mycophenolate decreases effects of zoster vaccine live by pharmacodynamic antagonism. Contraindicated. Immunosuppressants also increase risk of infection with concomitant live vaccines.</p></li>